Valens GroWorks (CSE:VGW) (OTC:VGWCF) CEO Tyler Robson joined Capital Ideas Radio recently to speak with host Mark Bunting regarding the company’s progress in the cannabis derivatives space. The company has been working to perfect its extraction methods in anticipation of the second wave of legalization, which will see the Canadian government create a regulatory framework for the production, distribution and sale of cannabis derivatives like edibles, tinctures and other goods. The company has positioned itself as a leader in the Canadian cannabis extraction business, which it hopes to offer as a white label service to other cannabis companies looking to manufacture cannabis derivatives.
“If you look at October, that’s when Health Canada is launching beverages, edibles, concentrates, and basically any type of derivative. If you look at the way Valens is positioned, any ancillary product has to get extracted first. So we’re uniquely positioned to tap into that market and be an effective and dominant player when legalization 2.0 comes.”
According to Robson, there are a number of consumer packaged goods companies eager to enter the cannabis space, however many can afford to be patient as the legalization of cannabis rolls out. As a leader in Canadian cannabis extraction, Valens has positioned itself to offer white label services to these companies that wish to join the cannabis industry but do not otherwise have the ability to manufacture cannabis derivatives. Robson believes that the cannabis industry will shift away from flower, creating a unique opportunity for Valens as it positions itself as Canadian extraction leaders.
To listen to the full interview, click here.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or